Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection

Wright, 1993, Etiology of fulminant hepatic failure: is another virus involved?, Gastroenterology, 104, 640, 10.1016/0016-5085(93)90437-H Alter, 1995, Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC), Semin Liver Dis, 15, 110, 10.1055/s-2007-1007268 Linnen, 1996, Molecular cloning all and disease association of hepatitis G virus: a transfusion-transmissible agent, Science, 271, 505, 10.1126/science.271.5248.505 Simons, 1995, Isolation of novel virus-like sequences associated with human hepatitis, Nature Med, 1, 564, 10.1038/nm0695-564 Zuckerman, 1996, Alphabet of hepatitis viruses (editorial), Lancet, 347, 558, 10.1016/S0140-6736(96)91267-2 Yoshiba, 1995, Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology, Lancet, 346, 1131, 10.1016/S0140-6736(95)91802-7 Tameda, 1996, Infection with GB virus C (GBV-C) in patients with fulminant hepatitis, J Hepatol, 25, 842, 10.1016/S0168-8278(96)80287-X Kao, 1996, GBV-C in the aetiology of fulminant hepatitis, Lancet, 347, 120, 10.1016/S0140-6736(96)90244-5 Mishiro, 1996, GBV-C in the aetiology of fulminant hepatitis, Lancet, 347, 120, 10.1016/S0140-6736(96)90244-5 Kuroki, 1996, Does GBV-C cause fulminant hepatitis in Japan?, Lancet, 347, 908, 10.1016/S0140-6736(96)91395-1 Sallie, 1996, GBV-C virus and fulminant hepatic failure, Lancet, 347, 1552, 10.1016/S0140-6736(96)90704-7 Heringlake, 1996, Association between fulminant hepatic failure and a strain of GBV virus C, Lancet, 348, 1626, 10.1016/S0140-6736(96)04413-3 Angus, 1995, Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation, Hepatology, 21, 14, 10.1002/hep.1840210104 Crofts, 1993, Hepatitis C virus infection among a cohort of Victorain injecting drug users, Med J Aust, 159, 237, 10.5694/j.1326-5377.1993.tb137822.x Moaven, 1995, The seroepidemiology of hepatitis E in selected Australian populations, J Med Virol, 45, 326, 10.1002/jmv.1890450316 Langnas, 1995, Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anaemia, Hepatology, 22, 1661 Tang, 1994, Parvovirus B19-associated red cell aplasia in combined immunodeficiency with normal immunoglobulins, Pediatr Infect Dis J, 13, 539, 10.1097/00006454-199406000-00015 Kwok, 1989, Avoiding false positives with PCR, Nature, 339, 237, 10.1038/339237a0 Chemczynski, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction, Anal Biochem, 167, 156 Moaven, 1996, Pervalence of hepatitis G virus in Queensland blood donors, Med J Aust, 165, 369, 10.5694/j.1326-5377.1996.tb125019.x Schlueter, 1996, Reverse transcription-PCR detection of hepatitis G virus, J Clin Microbiol, 34, 2660, 10.1128/JCM.34.11.2660-2664.1996 Wright, 1992, Hepatitis B virus and apparent fulminant non-A, non-B hepatitis, Lancet, 339, 952, 10.1016/0140-6736(92)91530-L Tacke, 1997, Detection of antibodies to a putative hepatitis G virus envelope protein, Lancet, 349, 318, 10.1016/S0140-6736(96)06461-6 Pilot-Matias, 1996, Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector sysetm and its utility as a serologic marker, Virology, 225, 282, 10.1006/viro.1996.0602 Berenguer, 1996, Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation, Gastroenterology, 111, 1569, 10.1016/S0016-5085(96)70019-7 Masuko, 1996, Infection with hepatitis GB virus C in patients on maintenace haemodialysis, N Engl J Med, 334, 1485, 10.1056/NEJM199606063342301 Alter, 1997, The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease, N Engl J Med, 336, 741, 10.1056/NEJM199703133361101